{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:11:59Z","timestamp":1793146319030,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-023-02010-w","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T15:34:30Z","timestamp":1677598470000},"page":"1573-1587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["CircOMA1 modulates cabergoline resistance by downregulating ferroptosis in prolactinoma"],"prefix":"10.1007","volume":"46","author":[{"given":"N.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"2010_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.beem.2019.101290","volume":"33","author":"P Chanson","year":"2019","unstructured":"Chanson P, Maiter D (2019) The epidemiology, diagnosis and treatment of Prolactinomas: the old and the new. Best Pract Res Clin Endocrinol Metab 33:1\u201322. https:\/\/doi.org\/10.1016\/j.beem.2019.101290","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2010_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14153604","volume":"14","author":"N Fukuhara","year":"2022","unstructured":"Fukuhara N, Nishiyama M, Iwasaki Y (2022) Update in pathogenesis, diagnosis, and therapy of Prolactinoma. Cancers 14:1\u201313. https:\/\/doi.org\/10.3390\/cancers14153604","journal-title":"Cancers"},{"key":"2010_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME (2017) Diagnosis and treatment of pituitary adenomas: a review. JAMA 317:516\u2013524. https:\/\/doi.org\/10.1001\/jama.2016.19699","journal-title":"JAMA"},{"key":"2010_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.nec.2019.05.001","volume":"30","author":"CM Faltermeier","year":"2019","unstructured":"Faltermeier CM, Magill ST, Blevins LS Jr, Aghi MK (2019) Molecular biology of pituitary adenomas. Neurosurg Clin N Am 30:391\u2013400. https:\/\/doi.org\/10.1016\/j.nec.2019.05.001","journal-title":"Neurosurg Clin N Am"},{"key":"2010_CR5","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"2010_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B (2022) Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer 22:381\u2013396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0","journal-title":"Nat Rev Cancer"},{"key":"2010_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H et al (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171:273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021","journal-title":"Cell"},{"key":"2010_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B (2021) Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12:599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5","journal-title":"Protein Cell"},{"key":"2010_CR9","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1089\/ars.2017.7176","volume":"29","author":"MJ Kerins","year":"2018","unstructured":"Kerins MJ, Ooi A (2018) The roles of NRF2 in modulating cellular iron homeostasis. Antioxid Redox Signal 29:1756\u20131773. https:\/\/doi.org\/10.1089\/ars.2017.7176","journal-title":"Antioxid Redox Signal"},{"key":"2010_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-14788-x","volume":"11","author":"Y Wei","year":"2020","unstructured":"Wei Y, Lu M, Mei M, Wang H, Han Z, Chen M, Yao H, Song N, Ding X, Ding J, Xiao M, Hu G (2020) Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection. Nat Commun 11:1\u201312. https:\/\/doi.org\/10.1038\/s41467-020-14788-x","journal-title":"Nat Commun"},{"key":"2010_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmet.2020.12.007","volume":"33","author":"YP Kang","year":"2021","unstructured":"Kang YP, Mockabee-Macias A, Jiang C, Falzone A, Prieto-Farigua N, Stone E, Harris IS, DeNicola GM (2021) Non-canonical glutamate-cysteine ligase activity protects against ferroptosis. Cell Metab 33:1\u201324. https:\/\/doi.org\/10.1016\/j.cmet.2020.12.007","journal-title":"Cell Metab"},{"key":"2010_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G (2021) Ferroptosis: molecular mechanisms and health implications. Cell Res 31:107\u2013125. https:\/\/doi.org\/10.1038\/s41422-020-00441-1","journal-title":"Cell Res"},{"key":"2010_CR13","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.7150\/thno.42174","volume":"10","author":"A Huang","year":"2020","unstructured":"Huang A, Zheng H, Wu Z, Chen M, Huang Y (2020) Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics 10:3503\u20133517. https:\/\/doi.org\/10.7150\/thno.42174","journal-title":"Theranostics"},{"key":"2010_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-022-01502-2","volume":"21","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yan Q, Mo Y, Liu Y, Wang Y, Zhang S, Guo C, Wang F, Li G, Zeng Z, Xiong W (2022) Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma tumorigenesis via a SERPINH1\/c-Myc positive feedback loop. Mol Cancer 21:1\u201320. https:\/\/doi.org\/10.1186\/s12943-022-01502-2","journal-title":"Mol Cancer"},{"key":"2010_CR15","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2018.01.012","volume":"68","author":"J Yu","year":"2018","unstructured":"Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma JZ, Sun SH, Yang F, Zhou WP (2018) Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol 68:1214\u20131227. https:\/\/doi.org\/10.1016\/j.jhep.2018.01.012","journal-title":"J Hepatol"},{"key":"2010_CR16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41388-022-02186-0","volume":"41","author":"W Zhang","year":"2022","unstructured":"Zhang W, Chen S, Du Q, Bian P, Chen Y, Liu Z, Zheng J, Sai K, Mou Y, Chen Z, Fan X, Jiang X (2022) CircVPS13C promotes pituitary adenoma growth by decreasing the stability of IFITM1 mRNA via interacting with RRBP1. Oncogene 41:1550\u20131562. https:\/\/doi.org\/10.1038\/s41388-022-02186-0","journal-title":"Oncogene"},{"key":"2010_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01281-8","volume":"19","author":"J Xu","year":"2020","unstructured":"Xu J, Wan Z, Tang M, Lin Z, Jiang S, Ji L, Gorshkov K, Mao Q, Xia S, Cen D, Zheng J, Liang X, Cai X (2020) N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating \u03b2-catenin signaling. Mol Cancer 19:1\u201316. https:\/\/doi.org\/10.1186\/s12943-020-01281-8","journal-title":"Mol Cancer"},{"key":"2010_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-019-1685-4","volume":"20","author":"WC Liang","year":"2019","unstructured":"Liang WC, Wong CW, Liang PP, Shi M, Cao Y, Rao ST, Tsui SK, Waye MM, Zhang Q, Fu WM, Zhang JF (2019) Translation of the circular RNA circ\u03b2-catenin promotes liver cancer cell growth through activation of the Wnt pathway. Genome Biol 20:1\u201312. https:\/\/doi.org\/10.1186\/s13059-019-1685-4","journal-title":"Genome Biol"},{"key":"2010_CR19","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1210\/jc.2018-01851","volume":"104","author":"Q Du","year":"2019","unstructured":"Du Q, Hu B, Feng Y, Wang Z, Wang X, Zhu D, Zhu Y, Jiang X, Wang H (2019) circOMA1-mediated miR-145-5p suppresses tumor growth of nonfunctioning pituitary adenomas by targeting TPT1. J Clin Endocrinol Metab 104:2419\u20132434. https:\/\/doi.org\/10.1210\/jc.2018-01851","journal-title":"J Clin Endocrinol Metab"},{"key":"2010_CR20","doi-asserted-by":"publisher","first-page":"35184","DOI":"10.18632\/oncotarget.17059","volume":"8","author":"S Moon","year":"2017","unstructured":"Moon S, Kim DK, Kim J (2017) Apoptosis-related microRNA-145-5p enhances the effects of pheophorbide a-based photodynamic therapy in oral cancer. Oncotarget 8:35184\u201335192. https:\/\/doi.org\/10.18632\/oncotarget.17059","journal-title":"Oncotarget"},{"key":"2010_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s40618-018-0963-4","volume":"42","author":"M Jian","year":"2019","unstructured":"Jian M, Du Q, Zhu D, Mao Z, Wang X, Feng Y, Xiao Z, Wang H, Zhu Y (2019) Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1. J Endocrinol Invest 42:639\u2013652. https:\/\/doi.org\/10.1007\/s40618-018-0963-4","journal-title":"J Endocrinol Invest"},{"key":"2010_CR22","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-18-0203","author":"Z Wu","year":"2018","unstructured":"Wu Z, Cai L, Lu J, Wang C, Guan J, Chen X, Wu J, Zheng W, Wu Z, Li Q, Su Z (2018) MicroRNA-93 mediates cabergoline-resistance by targeting ATG7 in prolactinoma. J Endocrinol. https:\/\/doi.org\/10.1530\/JOE-18-0203","journal-title":"J Endocrinol"},{"key":"2010_CR23","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1210\/jc.2017-00627","volume":"102","author":"SJ Lin","year":"2017","unstructured":"Lin SJ, Wu ZR, Cao L, Zhang Y, Leng ZG, Guo YH, Shang HB, Zhao WG, Zhang X, Wu ZB (2017) Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine. J Clin Endocrinol Metab 102:3692\u20133703. https:\/\/doi.org\/10.1210\/jc.2017-00627","journal-title":"J Clin Endocrinol Metab"},{"key":"2010_CR24","doi-asserted-by":"publisher","first-page":"6345","DOI":"10.1210\/jc.2019-00536","volume":"104","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu YT, Tang H, Xie WQ, Yao H, Gu WT, Zheng YZ, Shang HB, Wang Y, Wei YX, Wu ZR, Wu ZB (2019) Exosome-transmitted lncRNA H19 inhibits the growth of pituitary adenoma. J Clin Endocrinol Metab 104:6345\u20136356. https:\/\/doi.org\/10.1210\/jc.2019-00536","journal-title":"J Clin Endocrinol Metab"},{"key":"2010_CR25","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1021\/acscentsci.0c01592","volume":"7","author":"Y Fang","year":"2021","unstructured":"Fang Y, Chen X, Tan Q, Zhou H, Xu J, Gu Q (2021) Inhibiting ferroptosis through disrupting the NCOA4-FTH1 interaction: a new mechanism of action. ACS Cent Sci 7:980\u2013989. https:\/\/doi.org\/10.1021\/acscentsci.0c01592","journal-title":"ACS Cent Sci"},{"key":"2010_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41556-021-00818-3","volume":"24","author":"HL Zhang","year":"2022","unstructured":"Zhang HL, Hu BX, Li ZL, Du T, Shan JL, Ye ZP, Peng XD, Li X, Huang Y, Zhu XY, Chen YH, Feng GK, Yang D, Deng R, Zhu XF (2022) PKC\u03b2II phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nat Cell Biol 24:88\u201398. https:\/\/doi.org\/10.1038\/s41556-021-00818-3","journal-title":"Nat Cell Biol"},{"key":"2010_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1004-4","volume":"18","author":"Y Niu","year":"2019","unstructured":"Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun L, Wang Y, Li X, Xiong XF, Wei B, Wu X, Wan G (2019) RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer 18:1\u201316. https:\/\/doi.org\/10.1186\/s12943-019-1004-4","journal-title":"Mol Cancer"},{"key":"2010_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2021.111227","volume":"136","author":"N Wu","year":"2021","unstructured":"Wu N, Li J, Luo H, Wang D, Bai X (2021) Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer. Biomed Pharmacother 136:1\u201310. https:\/\/doi.org\/10.1016\/j.biopha.2021.111227","journal-title":"Biomed Pharmacother"},{"key":"2010_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/ars.2017.7172","volume":"30","author":"X Zeng","year":"2019","unstructured":"Zeng X, Yang J, Hu O, Huang J, Ran L, Chen M, Zhang Y, Zhou X, Zhu J, Zhang Q, Yi L, Mi M (2019) Dihydromyricetin ameliorates nonalcoholic fatty liver disease by improving mitochondrial respiratory capacity and redox homeostasis through modulation of SIRT3 signaling. Antioxid Redox Signal 30:163\u2013183. https:\/\/doi.org\/10.1089\/ars.2017.7172","journal-title":"Antioxid Redox Signal"},{"key":"2010_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-022-01599-5","volume":"21","author":"L Meng","year":"2022","unstructured":"Meng L, Zhang Y, Wu P, Li D, Lu Y, Shen P, Yang T, Shi G, Chen Q, Yuan H, Ge W, Miao Y, Tu M, Jiang K (2022) CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2. Mol Cancer 21:1\u201323. https:\/\/doi.org\/10.1186\/s12943-022-01599-5","journal-title":"Mol Cancer"},{"key":"2010_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1694-y","volume":"10","author":"C Wang","year":"2019","unstructured":"Wang C, Tan C, Wen Y, Zhang D, Li G, Chang L, Su J, Wang X (2019) FOXP1-induced lncRNA CLRN1-AS1 acts as a tumor suppressor in pituitary prolactinoma by repressing the autophagy via inactivating Wnt\/\u03b2-catenin signaling pathway. Cell Death Dis 10:1\u201313. https:\/\/doi.org\/10.1038\/s41419-019-1694-y","journal-title":"Cell Death Dis"},{"key":"2010_CR32","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/15548627.2019.163494","volume":"16","author":"X Chen","year":"2020","unstructured":"Chen X, Mao R, Su W, Yang X, Geng Q, Guo C, Wang Z, Wang J, Kresty LA, Beer DG, Chang AC, Chen G (2020) Circular RNA circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA\/AMPK\u03b1 signaling in STK11 mutant lung cancer. Autophagy 16:659\u2013671. https:\/\/doi.org\/10.1080\/15548627.2019.163494","journal-title":"Autophagy"},{"key":"2010_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2046448","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang H, Chen H, Li H, Xu P, Liu B, Zhang Q, Lv C, Song X (2022) ATF3 -activated accelerating effect of LINC00941\/lncIAPF on fibroblast-to-myofibroblast differentiation by blocking autophagy depending on ELAVL1\/HuR in pulmonary fibrosis. Autophagy. https:\/\/doi.org\/10.1080\/15548627.2022.2046448","journal-title":"Autophagy"},{"key":"2010_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M (2019) Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer 19:405\u2013414. https:\/\/doi.org\/10.1038\/s41568-019-0149-1","journal-title":"Nat Rev Cancer"},{"key":"2010_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/oncsis.2017.6","volume":"6","author":"Z Fan","year":"2017","unstructured":"Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M, Buchfelder M, Savaskan N (2017) Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis 6:1\u201314. https:\/\/doi.org\/10.1038\/oncsis.2017.6","journal-title":"Oncogenesis"},{"key":"2010_CR36","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng J, Conrad M (2020) The metabolic underpinnings of ferroptosis. Cell Metab 32:920\u2013937. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.011","journal-title":"Cell Metab"},{"key":"2010_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, Galeas J, Dhruv HD, Berens ME, Schreiber SL, McCormick F, McManus MT (2017) Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 551:247\u2013250. https:\/\/doi.org\/10.1038\/nature24297","journal-title":"Nature"},{"key":"2010_CR38","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1007\/s13311-020-00929-z","volume":"17","author":"Y Tian","year":"2020","unstructured":"Tian Y, Lu J, Hao X, Li H, Zhang G, Liu X, Li X, Zhao C, Kuang W, Chen D, Zhu M (2020) FTH1 inhibits ferroptosis through ferritinophagy in the 6-OHDA model of Parkinson\u2019s disease. Neurotherapeutics 17:1796\u20131812. https:\/\/doi.org\/10.1007\/s13311-020-00929-z","journal-title":"Neurotherapeutics"},{"key":"2010_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R, Tang D (2016) Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63:173\u2013184. https:\/\/doi.org\/10.1002\/hep.28251","journal-title":"Hepatology"},{"key":"2010_CR40","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.molcel.2017.09.009","volume":"68","author":"D Chen","year":"2017","unstructured":"Chen D, Tavana O, Chu B, Erber L, Chen Y, Baer R, Gu W (2017) NRF2 is a major target of ARF in p53-independent tumor suppression. Mol Cell 68:224\u2013232. https:\/\/doi.org\/10.1016\/j.molcel.2017.09.009","journal-title":"Mol Cell"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02010-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02010-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02010-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T10:26:03Z","timestamp":1689330363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02010-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["2010"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02010-w","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"4 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University (No: 2020-091).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"All animal studies were performed in the Laboratory Animal Center of Sun Yat-sen University and were conducted in accordance with the institutional policies for animal care.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Written informed consent was obtained from all patients involved in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}